Archive > Volume 14 Issue 2 > 2007,14(2):105-109. DOI:10.3872/j.issn.1007-385X.2007.2.002 Prev Next

Expert Forum

EGFR mutations and targeted therapy with tyrosine kinases inhibitors in non-small cell lung cancer

您是第位访问者
Supported by:Beijing E-Tiller Technology Development Co., Ltd.